Hospital Universitari Vall d´Hebron together with Vall d’Hebron Institute of Oncology (VHIO) have recently been recognized as Center of Excellence by the European Neuroendocrine Tumor Society (ENETS). This is the first center in Spain to join the large group of ENETS Centers of Excellence for the diagnosis, treatment and care of patients with neuroendocrine cancer in Europe. It is for this reason that the Spanish Association of Patients with Neuroendocrine Tumors, NET-ESPAÑA, interviewed Dr. Jaume Capdevila, Director of the multidisciplinary team at the ENETS Center of Excellence in Vall d´Hebron.
Dr. Jaume Capdevila is an oncologist, specialized in neuroendocrine neoplasms, who works in the Gastrointestinal and Endocrine Cancer unit within the Oncology Service at Hospital Universitari Vall d´Hebron. He also carries out his research activity at Vall d’Hebron Institute of Oncology (VHIO) and participates in multiple national and international research projects. He is currently President of the Spanish Group for Endocrine and Neuroendocrine Tumors (GETNE).